In a clinical trial, efficacy refers to a health product’s ability to provide the anticipated benefit, such as relieving a symptom, treating a disease, or slowing its progression, to a group of patients most likely to benefit from the treatment.
Subscribe to our newsletter!
Follow the latest news from CATALIS and Clinical Trials Quebec